Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Crispr Therapeutics AG, Common Stock

CRSP

NMQ

$62.91

+$1.17

(1.9%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$5.34B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

1.04M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

1.35M

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.78

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$37.55 L

$91.1 H

$62.91

About Crispr Therapeutics AG, Common Stock

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, immune-oncology and autoimmune, in vivo, and type 1 diabetes. The company's lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease, and hemoglobinopathies in which a patient's hematopoietic stem and progenitor cells are edited to produce high levels of fetal hemoglobin in red blood cells. It also develops CAR T cell therapies, including CTX112 targeting CD19 and CTX131 targeting CD70 for oncology and autoimmunune indications; CTX310 and CTX320, in vivo gene editing to address the cardiovascular disease by disrupting the validated targets angiopoietin-like protein 3 and lipoprotein; and VCTX211, an allogeneic, gene-edited, hypoimmune stem cell-derived product candidate for the treatment of T1D. It has strategic partnerships with Vertex Pharmaceuticals Incorporated, ViaCyte, Inc., Nkarta, Inc., and Capsida Biotherapeutics. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	CRSP	Sector	S&P500;
1-Week Return	-3.3%	-0.25%	0.25%
1-Month Return	-18.11%	-2.9%	0.89%
3-Month Return	-2.98%	0.87%	8.31%
6-Month Return	40.64%	9.38%	18.76%
1-Year Return	38.54%	7.5%	27.47%
3-Year Return	-45%	25.66%	30.79%
5-Year Return	67.72%	70.29%	93.94%
10-Year Return	346.49%	198.64%	241.45%

Time Frame	CRSP	Sector	S&P500;
1-Week Return	-82.62%	-12.24%	13.90%
1-Month Return	-91.20%	-30.10%	11.38%
3-Month Return	-11.55%	3.58%	38.23%
6-Month Return	99.68%	19.94%	41.71%
1-Year Return	38.54%	7.50%	27.47%
3-Year Return	-18.07%	7.91%	9.36%
5-Year Return	10.90%	11.23%	14.17%
10-Year Return	16.14%	11.56%	13.07%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	289.59M	543.00K	913.08M	436.00K	370.00M	[{"date":"2019-12-31","value":31.72,"profit":true},{"date":"2020-12-31","value":0.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.05,"profit":true},{"date":"2023-12-31","value":40.52,"profit":true}]
Cost of Revenue	179.36M	269.41M	101.18M	110.25M	130.25M	[{"date":"2019-12-31","value":66.58,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":37.56,"profit":true},{"date":"2022-12-31","value":40.92,"profit":true},{"date":"2023-12-31","value":48.35,"profit":true}]
Gross Profit	289.59M	(268.86M)	913.08M	(109.81M)	239.75M	[{"date":"2019-12-31","value":31.72,"profit":true},{"date":"2020-12-31","value":-29.45,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-12.03,"profit":false},{"date":"2023-12-31","value":26.26,"profit":true}]
Gross Margin	100.00%	(49514.55%)	100.00%	(25186.70%)	64.80%	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-49514.55,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-25186.7,"profit":false},{"date":"2023-12-31","value":64.8,"profit":true}]

Operating Expenses	242.85M	354.98M	539.55M	563.35M	462.29M	[{"date":"2019-12-31","value":43.11,"profit":true},{"date":"2020-12-31","value":63.01,"profit":true},{"date":"2021-12-31","value":95.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.06,"profit":true}]
Operating Income	46.74M	(354.44M)	373.53M	(673.16M)	(222.54M)	[{"date":"2019-12-31","value":12.51,"profit":true},{"date":"2020-12-31","value":-94.89,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-180.22,"profit":false},{"date":"2023-12-31","value":-59.58,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	67.31M	(348.06M)	379.53M	(650.50M)	(150.72M)	[{"date":"2019-12-31","value":17.73,"profit":true},{"date":"2020-12-31","value":-91.71,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-171.4,"profit":false},{"date":"2023-12-31","value":-39.71,"profit":false}]
Income Taxes	448.00K	809.00K	1.87M	(325.00K)	2.89M	[{"date":"2019-12-31","value":15.51,"profit":true},{"date":"2020-12-31","value":28.01,"profit":true},{"date":"2021-12-31","value":64.75,"profit":true},{"date":"2022-12-31","value":-11.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	66.86M	(348.87M)	377.66M	(650.17M)	(153.61M)	[{"date":"2019-12-31","value":17.7,"profit":true},{"date":"2020-12-31","value":-92.38,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-172.16,"profit":false},{"date":"2023-12-31","value":-40.67,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	66.86M	(348.87M)	377.66M	(650.17M)	(153.61M)	[{"date":"2019-12-31","value":17.7,"profit":true},{"date":"2020-12-31","value":-92.38,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-172.16,"profit":false},{"date":"2023-12-31","value":-40.67,"profit":false}]

EPS (Diluted)	0.97	(5.27)	4.42	(8.37)	(1.96)	[{"date":"2019-12-31","value":21.95,"profit":true},{"date":"2020-12-31","value":-119.23,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-189.37,"profit":false},{"date":"2023-12-31","value":-44.34,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	(99.81%)	168054.88%	(99.95%)	84762.39%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.06,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.06,"profit":false},{"date":"2023-12-31","value":50.44,"profit":true}]
Cost of Revenue	-	50.20%	(62.44%)	8.97%	18.14%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-124.38,"profit":false},{"date":"2022-12-31","value":17.86,"profit":true},{"date":"2023-12-31","value":36.13,"profit":true}]
Gross Profit	-	(192.84%)	(439.61%)	(112.03%)	(318.32%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Gross Margin	-	(49614.55%)	(100.20%)	(25286.70%)	(100.26%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Operating Expenses	-	46.17%	52.00%	4.41%	(17.94%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":88.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.48,"profit":true},{"date":"2023-12-31","value":-34.5,"profit":false}]
Operating Income	-	(858.31%)	(205.39%)	(280.22%)	(66.94%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(617.12%)	(209.04%)	(271.40%)	(76.83%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	80.58%	131.15%	(117.38%)	(988.62%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":61.44,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-89.5,"profit":false},{"date":"2023-12-31","value":-753.81,"profit":false}]
Income After Taxes	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(621.80%)	(208.25%)	(272.16%)	(76.37%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(621.80%)	(208.25%)	(272.16%)	(76.37%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	(643.30%)	(183.87%)	(289.37%)	(76.58%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	6.00K	100.00M	70.00M	-	200.00M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":50,"profit":true},{"date":"2023-06-30","value":35,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	6.82M	42.19M	44.64M	23.42M	20.00M	[{"date":"2022-12-31","value":15.29,"profit":true},{"date":"2023-03-31","value":94.52,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":52.47,"profit":true},{"date":"2023-12-31","value":44.81,"profit":true}]
Gross Profit	(6.82M)	57.81M	25.36M	(23.42M)	180.00M	[{"date":"2022-12-31","value":-3.79,"profit":false},{"date":"2023-03-31","value":32.12,"profit":true},{"date":"2023-06-30","value":14.09,"profit":true},{"date":"2023-09-30","value":-13.01,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	(113616.67%)	57.81%	36.23%	-	90.00%	[{"date":"2022-12-31","value":-126240.74,"profit":false},{"date":"2023-03-31","value":64.23,"profit":true},{"date":"2023-06-30","value":40.26,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	124.72M	122.30M	120.59M	108.99M	110.42M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":98.05,"profit":true},{"date":"2023-06-30","value":96.68,"profit":true},{"date":"2023-09-30","value":87.38,"profit":true},{"date":"2023-12-31","value":88.53,"profit":true}]
Operating Income	(131.54M)	(64.49M)	(95.22M)	(132.41M)	69.58M	[{"date":"2022-12-31","value":-189.04,"profit":false},{"date":"2023-03-31","value":-92.68,"profit":false},{"date":"2023-06-30","value":-136.85,"profit":false},{"date":"2023-09-30","value":-190.29,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	(120.05M)	(51.74M)	(76.82M)	(111.74M)	89.58M	[{"date":"2022-12-31","value":-134.02,"profit":false},{"date":"2023-03-31","value":-57.76,"profit":false},{"date":"2023-06-30","value":-85.75,"profit":false},{"date":"2023-09-30","value":-124.74,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes	(9.48M)	1.32M	923.00K	(412.00K)	233.00K	[{"date":"2022-12-31","value":-717.88,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":69.92,"profit":true},{"date":"2023-09-30","value":-31.21,"profit":false},{"date":"2023-12-31","value":17.65,"profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(110.58M)	(53.06M)	(77.74M)	(112.15M)	89.35M	[{"date":"2022-12-31","value":-123.76,"profit":false},{"date":"2023-03-31","value":-59.39,"profit":false},{"date":"2023-06-30","value":-87.01,"profit":false},{"date":"2023-09-30","value":-125.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(110.58M)	(53.06M)	(77.74M)	(112.15M)	89.35M	[{"date":"2022-12-31","value":-123.76,"profit":false},{"date":"2023-03-31","value":-59.39,"profit":false},{"date":"2023-06-30","value":-87.01,"profit":false},{"date":"2023-09-30","value":-125.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

EPS (Diluted)	(1.41)	(0.67)	(0.98)	(1.41)	1.10	[{"date":"2022-12-31","value":-128.18,"profit":false},{"date":"2023-03-31","value":-60.91,"profit":false},{"date":"2023-06-30","value":-89.09,"profit":false},{"date":"2023-09-30","value":-128.18,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	-	1666566.67%	(30.00%)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	518.38%	5.79%	(47.53%)	(14.61%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":1.12,"profit":true},{"date":"2023-09-30","value":-9.17,"profit":false},{"date":"2023-12-31","value":-2.82,"profit":false}]
Gross Profit	-	(948.00%)	(56.12%)	(192.34%)	(868.51%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Gross Margin	-	(100.05%)	(37.32%)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	(1.95%)	(1.40%)	(9.62%)	1.31%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-148.64,"profit":false},{"date":"2023-06-30","value":-106.59,"profit":false},{"date":"2023-09-30","value":-734.07,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	(50.98%)	47.66%	39.05%	(152.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-106.95,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":81.94,"profit":true},{"date":"2023-12-31","value":-320.07,"profit":false}]
Total Non-Operating Income/Expense	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(56.90%)	48.45%	45.46%	(180.17%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-117.43,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":93.83,"profit":true},{"date":"2023-12-31","value":-371.84,"profit":false}]
Income Taxes	-	(113.93%)	(30.08%)	(144.64%)	(156.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Income After Taxes	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(52.01%)	46.50%	44.27%	(179.67%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-111.85,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":95.2,"profit":true},{"date":"2023-12-31","value":-386.38,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(52.01%)	46.50%	44.27%	(179.67%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-111.85,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":95.2,"profit":true},{"date":"2023-12-31","value":-386.38,"profit":false}]

EPS (Diluted)	-	(52.48%)	46.27%	43.88%	(178.01%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-113.43,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":94.83,"profit":true},{"date":"2023-12-31","value":-384.74,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	987.55M	1.72B	2.42B	1.85B	1.91B	[{"date":"2019-12-31","value":40.85,"profit":true},{"date":"2020-12-31","value":71.01,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":76.65,"profit":true},{"date":"2023-12-31","value":78.93,"profit":true}]
Non-current Assets	79.20M	111.35M	334.36M	390.03M	321.49M	[{"date":"2019-12-31","value":20.31,"profit":true},{"date":"2020-12-31","value":28.55,"profit":true},{"date":"2021-12-31","value":85.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.43,"profit":true}]
Total Assets	1.07B	1.83B	2.75B	2.24B	2.23B	[{"date":"2019-12-31","value":38.76,"profit":true},{"date":"2020-12-31","value":66.43,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.51,"profit":true},{"date":"2023-12-31","value":81.02,"profit":true}]

Total Liabilities
Current Liabilities	57.11M	94.26M	119.88M	121.11M	108.79M	[{"date":"2019-12-31","value":47.15,"profit":true},{"date":"2020-12-31","value":77.83,"profit":true},{"date":"2021-12-31","value":98.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.83,"profit":true}]
Non-current Liabilities	70.22M	69.47M	232.53M	246.47M	237.98M	[{"date":"2019-12-31","value":28.49,"profit":true},{"date":"2020-12-31","value":28.19,"profit":true},{"date":"2021-12-31","value":94.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.55,"profit":true}]
Total Liabilities	127.33M	163.73M	352.42M	367.58M	346.77M	[{"date":"2019-12-31","value":34.64,"profit":true},{"date":"2020-12-31","value":44.54,"profit":true},{"date":"2021-12-31","value":95.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.34,"profit":true}]

Total Shareholders' equity
Common Stock	1.85M	2.28M	2.39M	2.44M	2.50M	[{"date":"2019-12-31","value":73.97,"profit":true},{"date":"2020-12-31","value":91.19,"profit":true},{"date":"2021-12-31","value":95.75,"profit":true},{"date":"2022-12-31","value":97.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(224.71M)	(573.58M)	(195.91M)	(846.09M)	(999.70M)	[{"date":"2019-12-31","value":-22471100000,"profit":false},{"date":"2020-12-31","value":-57357600000,"profit":false},{"date":"2021-12-31","value":-19591500000,"profit":false},{"date":"2022-12-31","value":-84609000000,"profit":false},{"date":"2023-12-31","value":-99970000000,"profit":false}]
Other Stockholders' Equity	1.16B	2.24B	2.60B	2.73B	2.88B	[{"date":"2019-12-31","value":40.38,"profit":true},{"date":"2020-12-31","value":77.68,"profit":true},{"date":"2021-12-31","value":90.27,"profit":true},{"date":"2022-12-31","value":95.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	939.42M	1.66B	2.40B	1.88B	1.88B	[{"date":"2019-12-31","value":39.15,"profit":true},{"date":"2020-12-31","value":69.36,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.16,"profit":true},{"date":"2023-12-31","value":78.47,"profit":true}]

Total Liabilities & Shareholders Equity	1.07B	1.83B	2.75B	2.24B	2.23B	[{"date":"2019-12-31","value":38.76,"profit":true},{"date":"2020-12-31","value":66.43,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.51,"profit":true},{"date":"2023-12-31","value":81.02,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	73.83%	40.83%	(23.35%)	2.97%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":55.3,"profit":true},{"date":"2022-12-31","value":-31.63,"profit":false},{"date":"2023-12-31","value":4.02,"profit":true}]
Non-current Assets	-	40.58%	200.29%	16.65%	(17.57%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":20.26,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.31,"profit":true},{"date":"2023-12-31","value":-8.77,"profit":false}]
Total Assets	-	71.36%	50.54%	(18.49%)	(0.60%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":70.83,"profit":true},{"date":"2022-12-31","value":-25.91,"profit":false},{"date":"2023-12-31","value":-0.84,"profit":false}]

Total Liabilities
Current Liabilities	-	65.06%	27.18%	1.02%	(10.17%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.78,"profit":true},{"date":"2022-12-31","value":1.57,"profit":true},{"date":"2023-12-31","value":-15.63,"profit":false}]
Non-current Liabilities	-	(1.07%)	234.71%	5.99%	(3.45%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.45,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":2.55,"profit":true},{"date":"2023-12-31","value":-1.47,"profit":false}]
Total Liabilities	-	28.59%	115.24%	4.30%	(5.66%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":24.81,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":3.73,"profit":true},{"date":"2023-12-31","value":-4.91,"profit":false}]

Total Shareholders' equity
Common Stock	-	23.28%	5.01%	2.09%	2.29%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":21.51,"profit":true},{"date":"2022-12-31","value":8.98,"profit":true},{"date":"2023-12-31","value":9.85,"profit":true}]
Retained Earnings	-	155.25%	(65.84%)	331.87%	18.16%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":46.78,"profit":true},{"date":"2021-12-31","value":-19.84,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.47,"profit":true}]
Other Stockholders' Equity	-	92.35%	16.21%	5.26%	5.24%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":17.56,"profit":true},{"date":"2022-12-31","value":5.7,"profit":true},{"date":"2023-12-31","value":5.67,"profit":true}]
Total Shareholders' equity	-	77.15%	44.18%	(21.84%)	0.39%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.26,"profit":true},{"date":"2022-12-31","value":-28.3,"profit":false},{"date":"2023-12-31","value":0.51,"profit":true}]

Total Liabilities & Shareholders Equity	-	71.36%	50.54%	(18.49%)	(0.60%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":70.83,"profit":true},{"date":"2022-12-31","value":-25.91,"profit":false},{"date":"2023-12-31","value":-0.84,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	1.85B	1.91B	1.86B	1.76B	1.91B	[{"date":"2022-12-31","value":97.11,"profit":true},{"date":"2023-03-31","value":99.99,"profit":true},{"date":"2023-06-30","value":97.46,"profit":true},{"date":"2023-09-30","value":92.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	390.03M	336.40M	337.44M	326.24M	321.49M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":86.25,"profit":true},{"date":"2023-06-30","value":86.52,"profit":true},{"date":"2023-09-30","value":83.65,"profit":true},{"date":"2023-12-31","value":82.43,"profit":true}]
Total Assets	2.24B	2.24B	2.20B	2.09B	2.23B	[{"date":"2022-12-31","value":99.94,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":97.89,"profit":true},{"date":"2023-09-30","value":92.98,"profit":true},{"date":"2023-12-31","value":99.34,"profit":true}]

Total Liabilities
Current Liabilities	121.11M	146.79M	132.84M	111.23M	108.79M	[{"date":"2022-12-31","value":82.5,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":90.49,"profit":true},{"date":"2023-09-30","value":75.78,"profit":true},{"date":"2023-12-31","value":74.11,"profit":true}]
Non-current Liabilities	246.47M	242.67M	248.15M	247.80M	237.98M	[{"date":"2022-12-31","value":99.32,"profit":true},{"date":"2023-03-31","value":97.79,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":99.86,"profit":true},{"date":"2023-12-31","value":95.9,"profit":true}]
Total Liabilities	367.58M	389.47M	380.99M	359.04M	346.77M	[{"date":"2022-12-31","value":94.38,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":97.82,"profit":true},{"date":"2023-09-30","value":92.19,"profit":true},{"date":"2023-12-31","value":89.04,"profit":true}]

Total Shareholders' equity
Common Stock	2.44M	2.45M	2.47M	2.48M	2.50M	[{"date":"2022-12-31","value":97.76,"profit":true},{"date":"2023-03-31","value":98.2,"profit":true},{"date":"2023-06-30","value":99.08,"profit":true},{"date":"2023-09-30","value":99.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(846.09M)	(899.15M)	(976.89M)	(1.09B)	(999.70M)	[{"date":"2022-12-31","value":-84609000000,"profit":false},{"date":"2023-03-31","value":-89915500000,"profit":false},{"date":"2023-06-30","value":-97689500000,"profit":false},{"date":"2023-09-30","value":-108904700000,"profit":false},{"date":"2023-12-31","value":-99970000000,"profit":false}]
Other Stockholders' Equity	2.73B	2.76B	2.80B	2.82B	2.88B	[{"date":"2022-12-31","value":95.02,"profit":true},{"date":"2023-03-31","value":95.93,"profit":true},{"date":"2023-06-30","value":97.26,"profit":true},{"date":"2023-09-30","value":98.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	1.88B	1.85B	1.82B	1.73B	1.88B	[{"date":"2022-12-31","value":99.61,"profit":true},{"date":"2023-03-31","value":98.52,"profit":true},{"date":"2023-06-30","value":96.45,"profit":true},{"date":"2023-09-30","value":91.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	2.24B	2.24B	2.20B	2.09B	2.23B	[{"date":"2022-12-31","value":99.94,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":97.89,"profit":true},{"date":"2023-09-30","value":92.98,"profit":true},{"date":"2023-12-31","value":99.34,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	-	2.96%	(2.54%)	(5.32%)	8.38%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":35.39,"profit":true},{"date":"2023-06-30","value":-30.28,"profit":false},{"date":"2023-09-30","value":-63.54,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	(13.75%)	0.31%	(3.32%)	(1.46%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-4430.84,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-1069.29,"profit":false},{"date":"2023-12-31","value":-469.24,"profit":false}]
Total Assets	-	0.06%	(2.11%)	(5.02%)	6.84%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":0.85,"profit":true},{"date":"2023-06-30","value":-30.84,"profit":false},{"date":"2023-09-30","value":-73.32,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	21.21%	(9.51%)	(16.26%)	(2.20%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-44.83,"profit":false},{"date":"2023-09-30","value":-76.67,"profit":false},{"date":"2023-12-31","value":-10.35,"profit":false}]
Non-current Liabilities	-	(1.54%)	2.26%	(0.14%)	(3.96%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-68.28,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-6.2,"profit":false},{"date":"2023-12-31","value":-175.74,"profit":false}]
Total Liabilities	-	5.96%	(2.18%)	(5.76%)	(3.42%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-36.57,"profit":false},{"date":"2023-09-30","value":-96.75,"profit":false},{"date":"2023-12-31","value":-57.38,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.45%	0.90%	0.08%	0.85%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":50.23,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":9.01,"profit":true},{"date":"2023-12-31","value":94.53,"profit":true}]
Retained Earnings	-	6.27%	8.65%	11.48%	(8.20%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":54.63,"profit":true},{"date":"2023-06-30","value":75.31,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-71.46,"profit":false}]
Other Stockholders' Equity	-	0.96%	1.39%	0.78%	2.02%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":47.5,"profit":true},{"date":"2023-06-30","value":68.87,"profit":true},{"date":"2023-09-30","value":38.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(1.10%)	(2.10%)	(4.86%)	8.97%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-12.23,"profit":false},{"date":"2023-06-30","value":-23.36,"profit":false},{"date":"2023-09-30","value":-54.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	0.06%	(2.11%)	(5.02%)	6.84%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":0.85,"profit":true},{"date":"2023-06-30","value":-30.84,"profit":false},{"date":"2023-09-30","value":-73.32,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	56.68M	(238.37M)	538.97M	(495.74M)	(260.38M)	[{"date":"2019-12-31","value":10.52,"profit":true},{"date":"2020-12-31","value":-44.23,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-91.98,"profit":false},{"date":"2023-12-31","value":-48.31,"profit":false}]

Investing Activities
Net Investing Cash Flow	1.32M	(541.17M)	(1.04B)	(258.65M)	-	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-40843.02,"profit":false},{"date":"2021-12-31","value":-78145.66,"profit":false},{"date":"2022-12-31","value":-19521.13,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	430.98M	1.02B	250.94M	38.59M	62.66M	[{"date":"2019-12-31","value":42.41,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":24.7,"profit":true},{"date":"2022-12-31","value":3.8,"profit":true},{"date":"2023-12-31","value":6.17,"profit":true}]

Net Change in Cash	489.00M	236.66M	(245.52M)	(715.88M)	177.01M	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":48.4,"profit":true},{"date":"2021-12-31","value":-50.21,"profit":false},{"date":"2022-12-31","value":-146.4,"profit":false},{"date":"2023-12-31","value":36.2,"profit":true}]

Free Cash Flow
Free Cash Flow	49.99M	(256.72M)	457.27M	(532.93M)	(272.35M)	[{"date":"2019-12-31","value":10.93,"profit":true},{"date":"2020-12-31","value":-56.14,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-116.55,"profit":false},{"date":"2023-12-31","value":-59.56,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(520.57%)	(326.11%)	(191.98%)	(47.48%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(40943.02%)	91.33%	(75.02%)	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-44828.9,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-82.14,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	135.78%	(75.30%)	(84.62%)	62.38%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-55.46,"profit":false},{"date":"2022-12-31","value":-62.32,"profit":false},{"date":"2023-12-31","value":45.94,"profit":true}]

Net Change in Cash	-	(51.60%)	(203.75%)	191.57%	(124.73%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-26.94,"profit":false},{"date":"2021-12-31","value":-106.35,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-65.11,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(613.52%)	(278.12%)	(216.55%)	(48.90%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	(113.33M)	8.80M	(133.25M)	(39.86M)	(96.07M)	[{"date":"2022-12-31","value":-1287.96,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-1514.32,"profit":false},{"date":"2023-09-30","value":-452.96,"profit":false},{"date":"2023-12-31","value":-1091.86,"profit":false}]

Investing Activities
Net Investing Cash Flow	(175.53M)	117.83M	216.92M	-	-	[{"date":"2022-12-31","value":-80.92,"profit":false},{"date":"2023-03-31","value":54.32,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	2.48M	5.40M	16.77M	1.56M	38.94M	[{"date":"2022-12-31","value":6.36,"profit":true},{"date":"2023-03-31","value":13.88,"profit":true},{"date":"2023-06-30","value":43.05,"profit":true},{"date":"2023-09-30","value":4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	(286.27M)	132.06M	100.47M	83.00M	(138.53M)	[{"date":"2022-12-31","value":-216.76,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":76.08,"profit":true},{"date":"2023-09-30","value":62.85,"profit":true},{"date":"2023-12-31","value":-104.89,"profit":false}]

Free Cash Flow
Free Cash Flow	(119.52M)	5.74M	(136.80M)	(41.97M)	(96.81M)	[{"date":"2022-12-31","value":-2082.21,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-2383.28,"profit":false},{"date":"2023-09-30","value":-731.25,"profit":false},{"date":"2023-12-31","value":-1686.6,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	-	(107.76%)	(1614.32%)	(70.09%)	141.05%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-76.4,"profit":false},{"date":"2023-06-30","value":-1144.5,"profit":false},{"date":"2023-09-30","value":-49.69,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(167.13%)	84.10%	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-198.72,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	118.08%	210.23%	(90.72%)	2402.51%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":4.91,"profit":true},{"date":"2023-06-30","value":8.75,"profit":true},{"date":"2023-09-30","value":-3.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	-	(146.13%)	(23.92%)	(17.39%)	(266.90%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(104.80%)	(2483.28%)	(69.32%)	130.65%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-80.22,"profit":false},{"date":"2023-06-30","value":-1900.78,"profit":false},{"date":"2023-09-30","value":-53.06,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	CRSP
Cash Ratio	15.57
Current Ratio	17.54

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CRSP
ROA (LTM)	-6.22%
ROE (LTM)	-8.17%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	CRSP
Debt Ratio Lower is generally better. Negative is bad.	0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.84
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	1.18

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CRSP
Trailing PE	NM
Forward PE	23.36
P/S (TTM)	13.39
P/B	2.78
Price/FCF	NM
EV/R	10.22
EV/Ebitda	NM
PEG	NM

News

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

Biotech stocks were among the worst performers in 2023. And so far in 2024, investors are still waiting on the recovery rally. Many small-cap biotech stocks are being held back by the Fed’s more restrictive stance on interest rates. But even some of the large-cap names with commercially available drugs that are household names are also underperforming the market. But “some” isn’t the same as “all.” In a stock picker’s market, you want to find the stocks that have a chance to outperform. One way to find these stocks is to look at analyst ratings. The three stocks in this article all have multiple Strong Buy ratings from analysts in addition to bullish price targets. Two of the stocks mentioned are Dividend Kings, which give you the added benefit of compounding as you hold the stock. Analyst ratings aren’t always an exact correlation, but they are a helpful way to narrow your focus and hone your research. That’s particularly important when it comes to the notoriously volatile biotech sector.

11 Apr, 2024 a 5:10 pm InvestorPlace

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

These companies are in the early days of their growth stories.

5 Apr, 2024 a 9:03 am The Motley Fool

Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?

CRISPR Therapeutics (NASDAQ:CRSP) stock has been falling over the past month. Without any milestone announcements since it gained its second U.S. r…

1 Apr, 2024 a 2:29 am TipRanks

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

Last year was a tough one for biotech stocks . The Securities and Exchange Commission reported 41 bankruptcies following the Fed’s interest rate hiking cycle, making it difficult to finance debt. Yet, by the end of the year, the biotech sector started to recover. Over one year, BlackRock’s iShares Biotechnology ETF (NASDAQ: IBB ) is now up 10%, but down -1.3% year-to-date. Due to negative market sentiment, some biotech stocks are more discounted than others. But which biotech stocks have sounder fundamentals? CRISPR Therapeutics (CRSP) Source: rafapress / Shutterstock.com CRISPR (NASDAQ: CRSP ), which stands for Clustered Regularly Interspaced Short Palindromic Repeats is a gene-editing tool adapted from bacterial defense to apply as molecular scissors. By cutting DNA fragments at certain points, CRISPR tech can potentially correct faulty genes and eliminate conditions stemming from them. In January, the company announced the FDA approval of gene-edited cell therapy CASGEVY for treating patients who require regular blood transfusions to stay alive.

28 Mar, 2024 a 12:39 pm InvestorPlace

3 Stocks That Could Be the Next Big Thing in Gene Editing

Gene editing could revolutionize how millions of patients are treated all over the world. That could create big opportunities for some of the most exciting gene-editing stocks. Look at gene editing stocks, like CRISPR Therapeutics (NASDAQ: CRSP ), for example. Several weeks ago, the U.S. Federal Drug Administration approved a new gene-editing treatment for sickle cell disease and transfusion-dependent beta-thalassemia, a genetic disorder that prevents the production of hemoglobin in the blood. Since then, CRSP has run from about $40 to a high of $90. Now back to $72.94, it’s oversold and could easily rally back to $90 soon. In fact, with a pipeline full of other potential treatments for immune-oncology, autoimmune diseases, cardiovascular disease and Type 1 diabetes, the CRSP stock could race higher. Plus, with gene editing gaining major traction, the market could be worth about $29.9 billion by the time 2032 rolls around, as noted by Precedence Research. Even better, there are plenty of other gene-editing stocks with similar potential.

21 Mar, 2024 a 8:19 pm InvestorPlace

3 Biopharma Stocks Predicted to Soar in Q2 2024

Biopharma stocks have been among the most popular and well-performing stocks this year. With recent trends in weight loss drugs and clinical advancements in treating illnesses, this market is set for significant advances this year. There’s no better time for investors to look into the companies leading the charge and the stocks expected to perform best. These three biopharma stocks have products capitalizing on the surging demand for the latest, most popular drugs this year. We’ll detail the developments of these companies’ latest drugs and their recent stock performance, which will excite investors looking for a profitable in Q2 of this year. CRISPR Therapeutics (CRSP) CRISPR Therapeutics (NASDAQ: CRSP ) is a leader in the new wave of gene-editing drugs undergoing clinical studies to be approved and used to treat complex conditions. This stock has long outperformed the S&P 500 market average in total returns and shows great promise for continuing its success this year. The most recent development for CRISPR Therapeutics is the approval of their new one-time sickle cell treatment CASGEVY in the U.S., E.U., Great Britain, Bahrain and the Kingdom of Saudi Arabia (KSA).

20 Mar, 2024 a 5:49 pm InvestorPlace

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Crispr Therapeutics AG share price today?

Crispr Therapeutics AG (CRSP) share price today is $62.91

Can Indians buy Crispr Therapeutics AG shares?

Yes, Indians can buy shares of Crispr Therapeutics AG (CRSP) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CRSP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Crispr Therapeutics AG be purchased?

Yes, you can purchase fractional shares of Crispr Therapeutics AG (CRSP) via the Vested app. You can start investing in Crispr Therapeutics AG (CRSP) with a minimum investment of $1.

How to invest in Crispr Therapeutics AG shares from India?

You can invest in shares of Crispr Therapeutics AG (CRSP) via Vested in three simple steps:

Click on Sign Up or Invest in CRSP stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Crispr Therapeutics AG shares

What is Crispr Therapeutics AG 52-week high and low stock price?

The 52-week high price of Crispr Therapeutics AG (CRSP) is $91.1. The 52-week low price of Crispr Therapeutics AG (CRSP) is $37.55.

What is Crispr Therapeutics AG price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Crispr Therapeutics AG (CRSP) is NM

What is Crispr Therapeutics AG price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Crispr Therapeutics AG (CRSP) is 2.78

What is Crispr Therapeutics AG dividend yield?

The dividend yield of Crispr Therapeutics AG (CRSP) is 0.00%

What is the Market Cap of Crispr Therapeutics AG?

The market capitalization of Crispr Therapeutics AG (CRSP) is $5.34B

What is Crispr Therapeutics AG’s stock symbol?

The stock symbol (or ticker) of Crispr Therapeutics AG is CRSP

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Crispr Therapeutics AG, Common Stock

CRSP

NMQ

$62.91

+$1.17

(1.9%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Crispr Therapeutics AG, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

3 Stocks That Could Be the Next Big Thing in Gene Editing

3 Biopharma Stocks Predicted to Soar in Q2 2024

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²